AH
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
1.524
Exchange
XNAS - Nasdaq
0.07 B
Last period Cash and equivalents ,USD
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Adapthealth
Company Analysis
AHCO valuation, rating, competitors, insights and company profile
Eyestock Rating
AHCO financial analysis by Eyestock methodology
Valuation
AHCO valuation using historical relative method
Statements
AHCO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
AHCO dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Adapthealth`s Cash and equivalents for the period ended 2024-06-30 are 0.07 B USD
